A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Clinical trial NCT00578825 · UNKNOWN
Trial details
- NCT number
- NCT00578825
- Sponsor
- Hospital Authority, Hong Kong
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.